GlassScriptPhysician profile
Prianka Sharma
NPI 1407207046
$2,341.50
in general payments reported to CMS, 2019-2025
25 companies · $138 in 2025
The $138 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $74.51 · 2020: $98.61 · 2021: $48.29 · 2022: $1,451 · 2023: $295 · 2024: $236 · 2025: $138.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $669.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $669.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Team 1, LLC | $1,200.00 | 2022 | |
| Smith+Nephew, INC. | $142.00 | 2022-2025 | Stravix |
| Horizon Therapeutics Plc | $140.66 | 2020-2023 | Krystexxa |
| Medtronic, INC. | $88.78 | 2023 | Venaseal, Intellis Adaptivestim |
| Bioventus LLC | $75.25 | 2022-2024 | Exogen Ultrasound Bone Healing System, Exogen Ultrasound Bone Healing System |
| Paratek Pharmaceuticals, INC. | $73.07 | 2022-2024 | Nuzyra |
| Zyla Life Sciences, INC. | $69.72 | 2019-2020 | |
| Averitas Pharma INC. | $67.62 | 2024-2025 | Qutenza |
| Aroa Biosurgery Incorporated | $60.62 | 2024 | |
| Amgen INC. | $49.88 | 2024-2025 | Krystexxa |
| Vertex Pharmaceuticals Incorporated | $47.99 | 2024-2025 | |
| In2bones USA, LLC | $41.24 | 2022 | |
| Treace Medical Concepts, INC. | $39.84 | 2022-2023 | |
| Crossroads Extremity Systems, LLC | $35.87 | 2019 | |
| Abbvie INC. | $25.77 | 2023 | Dalvance |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organogenesis INC. | $24.97 | 2024 | |
| Kerecis Limited | $23.91 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Stryker Corporation | $22.26 | 2020 | |
| Ani Pharmaceuticals, INC. | $20.30 | 2025 | Purified Cortrophin Gel |
| Next Science LLC | $19.13 | 2023 | Xperience, Surgx, Blastx |
| Paragon 28, INC. | $16.63 | 2021 | |
| Orthofix Medical, INC. | $15.16 | 2021 | |
| Tactile Systems Technology INC | $14.22 | 2022 | |
| Acera Surgical, INC. | $13.99 | 2019 | |
| Wright Medical Technology, INC. | $12.62 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Prianka Sharma listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.